International safety notice
TOTAL NUCLEAR ANTIBODY TO HEPATITIS B VIRUS (ANTI-HBCAG)
Brazil / Anvisa · BRA · Apr 20, 2016
Key facts
| Title | TOTAL NUCLEAR ANTIBODY TO HEPATITIS B VIRUS (ANTI-HBCAG) |
|---|---|
| Regulator | Brazil / Anvisa |
| Country | BRA |
| Brand | Commercial name of the product: ARCHITECT ANTI-HBc II CONTROLS / ARCHITECT ANTI-HBc II CONTROLES/// Registration number: 80146501604/// affected batch: 54570LI00/// Product risk class: IV. |
| Manufacturer | DETENTOR DO REGISTRO ABBOTT LABORATÓRIOS DO BRASIL CNPJ 56998701000116 RUA MICHIGAN 735 CIDADE MONÇÕES SÃO PAULO SP CEP 04566905TELEFONE PARA SUPORTE 55 11 5536 7246 FAX 55 11 5536 7062 FABRICANTE ABBOTT GMBH CO KG ENDEREÇO MAXPLANCKRING 2 65205 WIESBADEN GERMANY |
| Models | 54570LI00, 80146501604 |
| Date | Apr 20, 2016 |
| Regulator page | anvisa.gov.br |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1